Pharming Group has nominated Fabrice Chouraqui as the successor to CEO Sijmen de Vries. His appointment will be subject to approval at an Extraordinary General Meeting of Shareholders (EGM).
Upon his appointment, Chouraqui will join the Board of Directors, while De Vries will step down as CEO. To ensure a smooth transition, De Vries will remain as a strategic advisor until December 31, 2025.
Richard Peters, Chairman of the Board of Directors, highlighted the expertise Chouraqui brings to Pharming:
“Fabrice is a highly experienced leader in the international pharmaceutical and biotechnology sectors. He brings extensive global expertise across the entire biopharmaceutical value chain, which will support Pharming in its next phase of growth.”
Chouraqui has held senior leadership roles at Novartis and Bristol-Myers Squibb, bringing a wealth of industry knowledge to Pharming.
With this appointment, Pharming reinforces its commitment to continuity and international expansion in the biotech sector.
Leiden Bio Science Park welcomed a high-level Shanghai delegation, led by Vice Mayor Liu Duo, marking a key step toward international collaboration in life sciences. The visit, initiated by Shanghai, showcased mutual interest in innovation and partnership.
The Netherlands will host the NATO Summit on 24-25 June 2025 at the World Forum in The Hague, leading to significant traffic disruptions and security measures across the Randstad region from 22-26 June. Motorists can expect road closures on major routes, while public transport services will be adjusted, with certain trams and buses suspended, and travelers are advised to avoid the area or use alternative transportation options.
This summer, students and professionals passionate about pharmaceutical innovation have a unique opportunity to gain hands-on experience in modern drug development. The...